Editorial member
Pradeep K. Singh Department of Biochemistry, Weill Cornell Medical College of Cornell University, New York, USA
ResearcherID: E-6481-2010
ORCID: 0000-0002-3570-1005


Publications


Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., ... & Szeto, H. H. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology, 24(8), 1250-1261.

Singh, P. K., Bisai, A., & Singh, V. K. (2007). Enantioselective Friedel–Crafts alkylation of indoles with nitroalkenes catalyzed by a bis (oxazoline)–Cu (II) complex. Tetrahedron letters, 48(7), 1127-1129.

Singh, P. K., & Singh, V. K. (2009). Enantioselective Friedel− Crafts Alkylation of Pyrroles Catalyzed by PYBOX-DIPH-Zn (II) Complexes. Organic letters, 12(1), 80-83.

Singh, P. K., & Singh, V. K. (2008). Highly Enantioselective Friedel− Crafts Reaction of Indoles with 2-EnoylPyridine 1-Oxides Catalyzed by Chiral Pyridine 2, 6-Bis (5′, 5′-diphenyloxazoline)− Cu (II) Complexes. Organic letters, 10(18), 4121-4124.

Mullarky, E., Lucki, N. C., Zavareh, R. B., Anglin, J. L., Gomes, A. P., Nicolay, B. N., ... & Blenis, J. (2016). Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proceedings of the National Academy of Sciences, 113(7), 1778-1783.

Ray, S. K., Singh, P. K., Molleti, N., & Singh, V. K. (2012). Enantioselective synthesis of Coumarin derivatives by PYBOX-DIPH-Zn (II) complex catalyzed Michael reaction. The Journal of organic chemistry, 77(19), 8802-8808.

Bisai, A., Singh, P. K., & Singh, V. K. (2007). Enantioselective diethylzinc addition to aldehydes catalyzed by Ti (IV) complex of unsymmetrical chiral bis (sulfonamide) ligands of trans-cyclohexane 1, 2-diamine. Tetrahedron, 63(3), 598-601.

Ray, S. K., Singh, P. K., & Singh, V. K. (2011). Enantioselective Michael Addition of Malonates to 2-Enoylpyridine N-Oxides Catalyzed by Chiral Bisoxazoline–Zn (II) Complex. Organic letters, 13(21), 5812-5815.

Karreci, E. S., Fan, H., Uehara, M., Mihali, A. B., Singh, P. K., Kurdi, A. T., ... & Routray, S. (2016). Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice. Proceedings of the National Academy of Sciences, 113(52), E8425-E8432.

Karreci, E. S., Fan, H., Uehara, M., Mihali, A. B., Singh, P. K., Kurdi, A. T., ... & Routray, S. (2016). Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice. Proceedings of the National Academy of Sciences, 113(52), E8425-E8432.

Singh, P. K., & Singh, V. K. (2012). Chiral 2, 6-bis (5', 5'-diphenyloxazoline) pyridine as an efficient ligand for asymmetric catalysis. Pure and Applied Chemistry, 84(7), 1651-1657.

Singh, P. K., Fan, H., Jiang, X., Shi, L., Nathan, C. F., & Lin, G. (2016). Immunoproteasome β5i‐Selective Dipeptidomimetic Inhibitors. ChemMedChem, 11(19), 2127-2131.

Hsu, H. C., Singh, P. K., Fan, H., Wang, R., Sukenick, G., Nathan, C., ... & Li, H. (2016). Structural basis for the species-selective binding of N, C-capped dipeptides to the Mycobacterium tuberculosis proteasome. Biochemistry, 56(1), 324-333.

Santos, R. D. L. A., Bai, L., Singh, P. K., Murakami, N., Fan, H., Zhan, W., ... & Nathan, C. F. (2017). Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes. Nature communications, 8(1), 1692.

Santos, R. D. L. A., Bai, L., Singh, P. K., Murakami, N., Fan, H., Zhan, W., ... & Nathan, C. F. (2017). Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes. Nature communications, 8(1), 1692.